within Pharmacolibrary.Drugs.ATC.C;

model C07AA03
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.95,
    Cl             = 0.006666666666666667,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 15.0,            
    Vdp             = 0.003,
    k12             = 160,
    k21             = 160
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C07AA03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Pindolol is a non-selective beta-adrenergic blocker used primarily to treat hypertension and occasionally angina pectoris. It is an approved drug and has been widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers, primarily males and females, after a single oral dose.</p><h4>References</h4><ol><li><p>Aellig, WH (1982). Clinical pharmacology of pindolol. <i>American heart journal</i> 104(2 Pt 2) 346–356. DOI:<a href=&quot;https://doi.org/10.1016/0002-8703(82)90125-9&quot;>10.1016/0002-8703(82)90125-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6125094/&quot;>https://pubmed.ncbi.nlm.nih.gov/6125094</a></p></li><li><p>Safar, ME, et al., &amp; Weiss, YA (1978). Pharmacokinetics of intravenous and oral pindolol in hypertensive patients with chronic renal failure. <i>Clinical science and molecular medicine. Supplement</i> 4 275s–277s. DOI:<a href=&quot;https://doi.org/10.1042/cs055275s&quot;>10.1042/cs055275s</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/282067/&quot;>https://pubmed.ncbi.nlm.nih.gov/282067</a></p></li><li><p>Jennings, GL, et al., &amp; Korner, PI (1979). Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia. <i>British journal of clinical pharmacology</i> 7(3) 245–256. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1979.tb00929.x&quot;>10.1111/j.1365-2125.1979.tb00929.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/427002/&quot;>https://pubmed.ncbi.nlm.nih.gov/427002</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C07AA03;
